about
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASHA Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDOral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel diseaseAlcohol's Effect on Host DefenseTreatment of nonalcoholic steatohepatitis in adults: present and futureLeaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitisIntestinal microbiota in health and disease: role of bifidobacteria in gut homeostasisStudying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiologyAlcoholic hepatitis and HCV interactions in the modulation of liver diseaseDevelopmental origins of NAFLD: a womb with a clue.Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice.Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.New therapeutic targets in alcoholic hepatitis.Gut microbiota of liver transplantation recipients.Microbiota-liver axis in hepatic disease.The microbiota regulates susceptibility to Fas-mediated acute hepatic injuryBoth bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiotaMicro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice.Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.The gut microbiota and the liver: implications for clinical practice.Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitisGut microbiota modulate the immune effect against hepatitis B virus infection.MicroRNA Signature in Alcoholic Liver DiseaseHepatic TLR4 signaling in obese NAFLDIrritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome.Pathogenesis and Management of Alcoholic Liver Disease.Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidencesCase of severe alcoholic hepatitis treated with granulocytapheresis.The functional role of microRNAs in alcoholic liver injury.Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism.Molecular hepatic carcinogenesis: impact of inflammation.The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.Gut-liver axis in alcoholic liver diseaseGut-liver axis: role of inflammasomes.Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.New approaches for fibrosis regression in alcoholic cirrhosis.
P2860
Q26742102-5EEFD15C-A770-4757-A542-16987DBEDD7DQ26752487-3E7BC2CF-9C40-4A6C-A38C-01505AE2A5FFQ26768500-38A50E3F-772B-491F-82BF-A50F139F985DQ26773204-DD381072-B6FF-45BD-B3F0-AFBD0FDAE308Q26852403-8B670D63-B284-40DE-A531-7DF49D801727Q26991664-55649E84-A54D-4EE4-9907-9040AE3C920CQ27001712-2487A1C5-91AE-4084-83A6-4BD92C5DEA85Q27010291-531F2FA9-6574-4EC3-B7D0-8AFA46FEFA7DQ28084063-BF41FC5C-FAF2-492D-8A5E-C960605C656AQ30241940-946B511E-E55C-4847-8AEF-600BD46EDD61Q30397725-7CB77B85-9129-4723-B75D-04A6BFB69323Q33610049-43595120-FF42-4BB0-A66E-F1D629AF05F9Q33757267-D4AFAFEF-B277-4CCA-91EE-0E91307775EEQ33812705-19FF3ADE-C002-4427-A481-E8A716D024F8Q33855414-5F6CCC46-7A2A-43AE-A95F-0F633F84BB6FQ34122986-53923C68-F402-4DA2-AF14-818BC144438FQ34214279-D2904956-83AD-4616-A7CB-0064E6B6C3D4Q34256050-4F6E9022-38F2-42F4-A4A6-D78B5363484CQ34659613-A79DC0F4-489C-410E-BDD1-05792CCDD3A5Q34731373-C232F341-362B-4658-B355-8DAEAEFDFD1FQ34733841-C037E551-66A5-441F-A8C1-6817852D58B8Q34861969-EFA41F6C-4138-43D9-BFA1-B0829C1EE6A7Q35019661-DE4A0F93-4C0C-49EB-98AD-D3422AD87C76Q35031260-9A5DBB30-152E-42A1-928C-607FB683AD36Q35697286-2EB20CEF-22FE-4C67-BE25-2B5C0F4240A9Q35745517-CE69277F-7CAD-4717-826A-0A934085DB50Q35810474-7BB2EA31-93A5-451F-85F0-25E61E369A21Q35958528-84FF5581-0E5D-4248-9768-4F1F926459C7Q36418677-E411FB8F-79EA-4EBE-ADC1-C13278AAA186Q37011836-B2C9FEFC-DEDA-441B-A912-E95495DB189FQ37034650-21CCD8F2-E136-441A-8BB5-CCC32F0F95C9Q37418907-2276AD64-41DC-47F4-B803-7A70CF293E7AQ37595286-12B12C34-72F6-4EFB-A0ED-1686810D4115Q37727703-77C5BB03-9A43-4D93-8892-DF2846093E0FQ38020727-3C65FAE0-1661-4129-863E-B5BF1F3569D6Q38074434-B8007EC4-E5CD-485D-8997-0C19A6ADD90EQ38275213-22BA0310-0F46-4264-9384-F2A4906560DEQ38371533-D5F1F3AB-F315-4761-B6B8-E732BC1F9E91Q38750137-C7B676D4-3A5D-458F-97F3-A51B1DB1D090Q38909134-066CE2B7-0BC4-43CF-B72B-618D15ACE1BA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gut-liver axis and sensing microbes.
@en
Gut-liver axis and sensing microbes.
@nl
type
label
Gut-liver axis and sensing microbes.
@en
Gut-liver axis and sensing microbes.
@nl
prefLabel
Gut-liver axis and sensing microbes.
@en
Gut-liver axis and sensing microbes.
@nl
P2093
P2860
P356
P1433
P1476
Gut-liver axis and sensing microbes.
@en
P2093
Arijeet Gattu
Gyongyi Szabo
Jan Petrasek
Shashi Bala
P2860
P304
P356
10.1159/000324281
P577
2010-01-01T00:00:00Z